Athene Stock Forecast, Price & News

Athene's stock was trading at $31.16 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, ATH stock has increased by 43.4% and is now trading at $44.67.
View which stocks have been most impacted by COVID-19.

9 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Athene in the last year. There are currently 2 hold ratings and 7 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Athene stock.
View analyst ratings for Athene or view MarketBeat's top 5 stock picks.

Wall Street analysts have given Athene a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Athene wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

538 employees have rated Athene CEO Thomas Greco on Glassdoor.com. Thomas Greco has an approval rating of 63% among Athene's employees. This puts Thomas Greco in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

Athene is scheduled to release its next quarterly earnings announcement on Tuesday, February 16th 2021.
View our earnings forecast for Athene.

Athene Holding Ltd. (NYSE:ATH) released its earnings results on Sunday, November, 8th. The insurance provider reported $1.53 earnings per share (EPS) for the quarter, beating the Zacks' consensus estimate of $1.10 by $0.43. The insurance provider earned $1.21 billion during the quarter, compared to analyst estimates of $1.38 billion. The firm's quarterly revenue was up 10.9% compared to the same quarter last year. During the same quarter in the prior year, the company posted $1.34 EPS.
View Athene's earnings history.

9 brokers have issued 12 month target prices for Athene's stock. Their forecasts range from $34.00 to $72.00. On average, they expect Athene's share price to reach $48.22 in the next twelve months. This suggests a possible upside of 8.0% from the stock's current price.
View analysts' price targets for Athene or view Wall Street analyst' top-rated stocks.

Some companies that are related to Athene include Prudential Financial (PRU), Swiss Re (SSREY), Sun Life Financial (SLF), Aviva (AVVIY), Legal & General Group Plc (LGEN.L) (LGEN), Aegon (AEG), Sony Financial (SNYFY), Lincoln National (LNC), Globe Life (GL), Reinsurance Group of America (RGA), Voya Financial (VOYA), Scor (SCRYY), Primerica (PRI), Brighthouse Financial (BHF) and American Equity Investment Life (AEL).
View all of ATH's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Athene investors own include DocuSign (DOCU), AT&T (T), Alibaba Group (BABA), Intel (INTC), Applied Materials (AMAT), JD.com (JD), Okta (OKTA), Visa (V), Slack Technologies (WORK) and AbbVie (ABBV).

(ATH) raised $952 million in an IPO on Friday, December 9th 2016. The company issued 23,800,000 shares at a price of $38.00-$42.00 per share. Goldman Sachs, Barclays, Citigroup and Wells Fargo Securities acted as the underwriters for the IPO and BofA Merrill Lynch, BMO Capital Markets, Credit Suisse, Deutsche Bank Securities, J.P. Morgan, Morgan Stanley, RBC Capital Markets, BNP PARIBAS, BTIG, Evercore ISI, SunTrust Robinson Humphrey, UBS Investment Bank, Apollo Global Securities, Dowling & Partners Securities, Keefe, Bruyette & Woods (A Stifel Company), Lazard, Raymond James, Rothschild, Sandler O’Neill + Partners and The Williams Capital Group, L.P. were co-managers.

Athene trades on the New York Stock Exchange (NYSE) under the ticker symbol "ATH."

Athene's stock is owned by a number of retail and institutional investors. Top institutional investors include Gofen & Glossberg LLC IL (0.09%), Denali Advisors LLC (0.03%), DNB Asset Management AS (0.01%) and IFM Investors Pty Ltd (0.01%). Company insiders that own Athene stock include Frank Lauren Gillis, Grant Kvalheim, James Richard Belardi, Lawrence Ruisi, Marc A Beilinson, Martin P Klein and Robert L Borden.
View institutional ownership trends for Athene.

ATH stock was sold by a variety of institutional investors in the last quarter, including DNB Asset Management AS, and Gofen & Glossberg LLC IL.
View insider buying and selling activity for Athene or view top insider-selling stocks.

ATH stock was purchased by a variety of institutional investors in the last quarter, including IFM Investors Pty Ltd, and Denali Advisors LLC. Company insiders that have bought Athene stock in the last two years include Grant Kvalheim, James Richard Belardi, Marc A Beilinson, and Martin P Klein.
View insider buying and selling activity for Athene or or view top insider-buying stocks.

Shares of ATH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of ATH stock can currently be purchased for approximately $44.67.

Athene has a market capitalization of $8.55 billion and generates $16.26 billion in revenue each year. The insurance provider earns $2.17 billion in net income (profit) each year or $6.94 on an earnings per share basis. Athene employs 1,325 workers across the globe.

The official website for Athene is www.athene.com.

Athene's mailing address is 96 Pitts Bay Road, Pembroke D0, HM08. The insurance provider can be reached via phone at 441-279-8400 or via email at [email protected]